EUVIMEDEUVIMED entdecken
Crossref

Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System

Ryosuke Negoro, Ayu Ouchi, Sayaka Deguchi, Kazuo Takayama, Takuya Fujita

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b24-00202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Ryosuke Negoro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pharmacokinetics, College of Pharmaceutical Sciences, Ritsumeikan University. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Hepatocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CYP2D6 variants contain various single nucleotide polymorphisms as well as differing levels of metabolic activity. Among these, one of the less active variants CYP2D6*10 (100C > T) is the most prevalent mutation in East Asians, including Japanese. This mutation leads to an amino acid substitution from proline to serine, which reduces the stability of CYP2D6 and consequently decreases its metabolic activity. In this study, we used a genome editing technology called the Precise Integration into Target Chromosome (PITCh) system to stably express six drug-metabolizing enzymes (CYP3A4, POR, uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), CYP1A2, CYP2C19, CYP2C9, and CYP2D6*10) in HepG2 (CYP2D6*10 KI-HepG2) cells to examine the effect of CYP2D6*10 on drug metabolism prediction. The protein expression levels of CYP2D6 in CYP2D6*10 KI-HepG2 cells were reduced relative to those in the CYP3A4-POR-UGT1A1-CYP1A2-CYP2C19-CYP2C9-CYP2D6 knock-in-HepG2 (CYPs-UGT1A1 KI-HepG2) cells. Consistent with the CYP2D6 protein expression results, CYP2D6 metabolic activity in CYP2D6*10 KI-HepG2 cells was reduced relative to CYPs-UGT1A1 KI-HepG2 cells. We successfully generated CYP2D6*10 KI-HepG2 cells with highly expressed, functional CYP2D6*10, as well as CYP1A2, 2C9, 2C19 and 3A4. CYP2D6*10 KI-HepG2 cells could be an invaluable model for hepatic metabolism and hepatotoxicity studies in East Asians, including Japanese.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6HepatocytesHumansHep G2 CellsGene EditingGlucuronosyltransferasePolymorphism, Single NucleotideModels, Biological

Stichwörter der Autor:innen

CYP2D6CYP2D6*10HepG2 cellclustered regularly interspaced short palindromic repeats-CRISPR associated 9 (…genome editingprimary human hepatocyte

Substanzen

Cytochrome P-450 CYP2D6Glucuronosyltransferase

Autor:innen und Institutionen

  • Laboratory of Molecular Pharmacokinetics, College of Pharmaceutical Sciences, Ritsumeikan University.
  • Center for iPS Cell Research and Application (CiRA), Kyoto University.
  • AMED-CREST, AMED.
  • Research Center for Drug Discovery and Development, Ritsumeikan University.

Zitieren

APA

Negoro, R., Ouchi, A., Deguchi, S., Takayama, K., & Fujita, T. (2024). Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00202

Vancouver

Negoro R, Ouchi A, Deguchi S, Takayama K, Fujita T. Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b24-00202

BibTeX
@article{Negoro2024,
  author = {Negoro, Ryosuke and Ouchi, Ayu and Deguchi, Sayaka and Takayama, Kazuo and Fujita, Takuya},
  title = {Refining Hepatocyte Models to Capture the Impact of CYP2D6*10 Utilizing a PITCh System},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b24-00202}
}
Kostenlos starten →